Stock DZ
13.01.2018 kl 04:11
1387

The following is also positive:

“In 2017 and beyond, more than 85% of global market value will be attributed by extrahepatic Cholangiocarcinoma as a disease indicator.”

extrahepatic Cholangiocarcinoma is what Fimachem is mostly associated with.
Arkivert